Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kidswell Bio Corporation ( (JP:4584) ) just unveiled an update.
Kidswell Bio Corporation has released its financial results for the second quarter of fiscal year 2025, highlighting its progress in the biosimilars and cell therapy sectors. The announcement underscores the company’s strategic focus on expanding its market presence and improving its financial performance, which is crucial for its stakeholders and industry positioning.
The most recent analyst rating on (JP:4584) stock is a Hold with a Yen249.00 price target. To see the full list of analyst forecasts on Kidswell Bio Corporation stock, see the JP:4584 Stock Forecast page.
More about Kidswell Bio Corporation
Kidswell Bio Corporation operates in the biotechnology industry, focusing on creating value through biosimilars and cell therapy products. The company is dedicated to enhancing healthcare systems for children, families, and society.
Average Trading Volume: 1,497,603
Technical Sentiment Signal: Hold
Current Market Cap: Yen12.24B
Learn more about 4584 stock on TipRanks’ Stock Analysis page.